Two Sigma Securities, LLC Vascular Biogenics Ltd. Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.21 - $0.32 $11,040 - $16,823	52,572 New	52,572 $12,000
Q3 2022 Nov 14, 2022	BUY	$0.15 - $2.1 $7,720 - $108,084	51,469 Added 481.47%	62,159 $10,000
Q2 2022 Aug 15, 2022	SELL	$1.22 - $1.95 $1,787 - $2,856	-1,465 Reduced 12.05%	10,690 $17,000
Q1 2022 May 16, 2022	BUY	$1.15 - $1.97 $13,978 - $23,945	12,155 New	12,155 $21,000
Q4 2021 Feb 14, 2022	SELL	$1.92 - $2.53 $19,576 - $25,795	-10,196 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.94 - $2.55 $19,780 - $25,999	10,196 New	10,196 $21,000
Q2 2018 Aug 14, 2018	SELL	$2.05 - $3.0 $54,355 - $79,545	-26,515 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.27 - $8.5 $60,189 - $225,377	26,515 New	26,515 $61,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.